Biologics Biosimilars Market In-depth Research covering sales outlook, demand forecast & up-to-date key trends
Biologics Biosimilars Market In-depth Research covering sales outlook, demand forecast & up-to-date key trends
The Global Biologics Biosimilars Market investigation report contains Types, Application & all logical and factual briefs about market Overview, CAGR, Production Volume, Sales, Revenue with the regional analysis covers North America, Europe, Asia-Pacific, South America, Middle East & Africa & The top Players like Roche, Amgen, AbbVie, Sanofi-Aventis, Johnson & Johnson, Pfizer, Novo Nordisk, Eli Lilly, Novartis, Merck, 3sbio, Changchun High Tech, CP Guojian, Biotech, Gelgen, Innovent, Dong Bao, Ganlee, United Laboratories
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
The global Biologics Biosimilars market is expected to grow at a CAGR of 5.3% during the forecast period.
The global Biologics Biosimilars market is estimated to be about 194907.8 million US dollars in 2020.
The global Biologics Biosimilars market is estimated to reach 239357.9 million USD by 2026.
The global Biologics Biosimilars market is segmented by company, region (country), type and application. Participants, stakeholders, and other readers in the global Biologics Biosimilars market will be able to gain an advantage as they use reports as a powerful resource.
Biologics Biosimilars markets by category
Monoclonal Antibodies
Interferon
Erythropoietin
Insulin
Vaccines
Others
Biologics Biosimilars Market by Application (Percentage of Demand)
Tumor
Diabetes
Cardiovascular
Hemophilia
Others
Who are the leading companies in Biologics Biosimilars
Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
3sbio
Changchun High Tech
CP Guojian
Biotech
Gelgen
Innovent
Dong Bao
Ganlee
United Laboratories
Biologics Biosimilars markets by region:
In North America
In Latin America
Europe
The Asia-pacific
Middle East and Africa (MEA)
What are the main countries covered
The United States
Canada
Germany
France
UK
Italy
Russia
China
Japan
Korea
Southeast Asia
India
Australia
Brazil
Mexico
Argentina
Chile
Colombia
Egypt
Saudi Arabia
United Arab Emirates
Nigeria
South Africa
Which is the most profitable market
Among regions, North America/Europe/Asia Pacific accounted for the largest share of global personalized beauty equipment as rising consumer incomes led to increased spending at Biologics Biosimilars.
What methodology did you follow in your research
This study was conducted by our expert analysts through a combination of primary and secondary studies. The methodology we follow includes a demand-side assessment of the market and triangulation of this through supply-side analysis. The methodology is based on the use of standard market structures, methods, and definitions.
Who were the primary study respondents
We talk to stakeholders across the spectrum. Including C-level executives, distributors, product manufacturers, industry experts, etc.
What are the sources of secondary research
We conduct extensive secondary studies using proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations and research papers.
1. Introduction
1.1 Definition of the Market
1.2 Research Purpose
1.3 Scope of the Study
1.4 Stakeholders
1.5 Geography Coverage
1.6 Currency Under Consideration
1.7 Market Size Units
1.8 Review Cycle
2 Global Market Overview
2.1 Global Biologics Biosimilars Revenue and Growth Forecast 2014-2026
2.2 Global Biologics Biosimilars Market Size and Growth Forecast 2014-2026
2.3 Global Biologics Biosimilars Revenue by Region 2014-2026
2.4 Biologics Biosimilars Market Share by Major Regions 2014-2021
2.5 Biologics Biosimilars Gross Margin in Different Region 2014-2021
2.6 Global Biologics Biosimilars Market History Price and Forecast 2014-2026
2.7 Global Biologics Biosimilars Sales Market Share by Top Companies 2014-2021
3 Global Biologics Biosimilars Market by Type
3.1 Global Biologics Biosimilars Revenue and Growth Rate Segment by Types from 2014-2021
3.2 Global Biologics Biosimilars Market Size and Growth Rate Segment by Product Types from 2014-2021
3.3 Global Biologics Biosimilars Price Segment by Types from 2014-2021
3.4 Brief Introduction of Different Types
3.4.1 Monoclonal Antibodies
3.4.2 Interferon
3.4.3 Erythropoietin
3.4.4 Insulin
3.4.5 Vaccines
3.4.6 Others
4 Global Biologics Biosimilars Market by Application
4.1 Global Biologics Biosimilars Revenue and Growth Rate Segment by Applications from 2014-2021
4.2 Global Biologics Biosimilars Market Size and Growth Rate Segment by Product Applications from 2014-2021
4.3 Brief Introduction of Different Applications
4.3.1 Tumor
4.3.2 Diabetes
4.3.3 Cardiovascular
4.3.4 Hemophilia
4.3.5 Others
5 North America Biologics Biosimilars Market (Value, Market Size, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
5.1 North America Biologics Biosimilars Value ($) from 2014-2021
5.2 North America Biologics Biosimilars Market Size from 2014-2021
5.3 North America Biologics Biosimilars Price Change from 2014-2021
5.4 North America Biologics Biosimilars Import and Export from 2014-2021
5.5 North America Biologics Biosimilars Market Value ($) and Growth (%) by Type from 2014-2021
5.6 North America Biologics Biosimilars Market Value ($) and Growth (%) by Application from 2014-2021
5.7 North America Biologics Biosimilars Market Value ($) and Growth (%) by Countries from 2014-2021
5.7.1 The United States
5.7.2 Canada
5.8 Top North America Biologics Biosimilars Participants Value ($) and Market Share (%) in 2020
6 Europe Biologics Biosimilars Market (Value, Market Size, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
6.1 Europe Biologics Biosimilars Value ($) from 2014-2021
6.2 Europe Biologics Biosimilars Market Size from 2014-2021
6.3 Europe Biologics Biosimilars Price Change from 2014-2021
6.4 Europe Biologics Biosimilars Import and Export from 2014-2021
6.5 Europe Biologics Biosimilars Market Value ($) and Growth (%) by Type from 2014-2021
6.6 Europe Biologics Biosimilars Market Value ($) and Growth (%) by Application from 2014-2021
6.7 Europe Biologics Biosimilars Market Value ($) and Growth (%) by Countries from 2014-2021
6.7.1 Germany
6.7.2 France
6.7.3 UK
6.7.4 Italy
6.7.5 Russia
…
6.8 Top Europe Biologics Biosimilars Participants Value ($) and Market Share (%) in 2020
7 Asia-Pacific Biologics Biosimilars Market (Value, Market Size, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
7.1 Asia-Pacific Biologics Biosimilars Value ($) from 2014-2021
7.2 Asia-Pacific Biologics Biosimilars Market Size from 2014-2021
7.3 Asia-Pacific Biologics Biosimilars Price Change from 2014-2021
7.4 Asia-Pacific Biologics Biosimilars Import and Export from 2014-2021
7.5 Asia-Pacific Biologics Biosimilars Market Value ($) and Growth (%) by Type from 2014-2021
7.6 Asia-Pacific Biologics Biosimilars Market Value ($) and Growth (%) by Application from 2014-2021
7.7 Asia-Pacific Biologics Biosimilars Market Value ($) and Growth (%) by Countries from 2014-2021
7.7.1 China
7.7.2 Japan
7.7.3 Korea
7.7.4 Southeast Asia
7.7.5 India
7.7.6 Australia
…
7.8 Top Asia-Pacific Biologics Biosimilars Participants Value ($) and Market Share (%) in 2020
8 Latin America Biologics Biosimilars Market (Value, Market Size, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
8.1 Latin America Biologics Biosimilars Value ($) from 2014-2021
8.2 Latin America Biologics Biosimilars Market Size from 2014-2021
8.3 Latin America Biologics Biosimilars Price Change from 2014-2021
8.4 Latin America Biologics Biosimilars Import and Export from 2014-2021
8.5 Latin America Biologics Biosimilars Market Value ($) and Growth (%) by Type from 2014-2021
8.6 Latin America Biologics Biosimilars Market Value ($) and Growth (%) by Application from 2014-2021
8.7 Latin America Biologics Biosimilars Market Value ($) and Growth (%) by Countries from 2014-2021
8.7.1 Brazil
8.7.2 Mexico
8.7.3 Argentina
8.7.4 Chile
8.7.5 Colombia
…
8.8 Top Latin America Biologics Biosimilars Participants Value ($) and Market Share (%) in 2020
9 Middle East & Africa Biologics Biosimilars Market (Value, Market Size, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
9.1 Middle East & Africa Biologics Biosimilars Value ($) from 2014-2021
9.2 Middle East & Africa Biologics Biosimilars Market Size from 2014-2021
9.3 Middle East & Africa Biologics Biosimilars Price Change from 2014-2021
9.4 Middle East & Africa Biologics Biosimilars Import and Export from 2014-2021
9.5 Middle East & Africa Biologics Biosimilars Market Value ($) and Growth (%) by Type from 2014-2021
9.6 Middle East & Africa Biologics Biosimilars Market Value ($) and Growth (%) by Application from 2014-2021
9.7 Middle East & Africa Biologics Biosimilars Market Value ($) and Growth (%) by Countries from 2014-2021
9.7.1 Egypt
9.7.2 Saudi Arabia
9.7.3 United Arab Emirates
9.7.4 Nigeria
9.7.5 South Africa
…
9.8 Top Middle East & Africa Biologics Biosimilars Participants Value ($) and Market Share (%) in 2020
10. Global Level Competitive Intelligence – Company Profiles
10.1 Roche
10.1.1 Roche Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.1.2 Roche Sales, Value, Gross and Gross Margin from 2014-2021
10.1.3 Roche Value and Growth Change from 2014-2021
10.1.4 Roche Price Change from 2014-2021
10.1.5 Roche Product Offered
10.2 Amgen
10.2.1 Amgen Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.2.2 Amgen Sales, Value, Gross and Gross Margin from 2014-2021
10.2.3 Amgen Value and Growth Change from 2014-2021
10.2.4 Amgen Price Change from 2014-2021
10.2.5 Amgen Product Offered
10.3 AbbVie
10.3.1 AbbVie Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.3.2 AbbVie Sales, Value, Gross and Gross Margin from 2014-2021
10.3.3 AbbVie Value and Growth Change from 2014-2021
10.3.4 AbbVie Price Change from 2014-2021
10.3.5 AbbVie Product Offered
10.4 Sanofi-Aventis
10.4.1 Sanofi-Aventis Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.4.2 Sanofi-Aventis Sales, Value, Gross and Gross Margin from 2014-2021
10.4.3 Sanofi-Aventis Value and Growth Change from 2014-2021
10.4.4 Sanofi-Aventis Price Change from 2014-2021
10.4.5 Sanofi-Aventis Product Offered
10.5 Johnson & Johnson
10.5.1 Johnson & Johnson Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.5.2 Johnson & Johnson Sales, Value, Gross and Gross Margin from 2014-2021
10.5.3 Johnson & Johnson Value and Growth Change from 2014-2021
10.5.4 Johnson & Johnson Price Change from 2014-2021
10.5.5 Johnson & Johnson Product Offered
10.6 Pfizer
10.6.1 Pfizer Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.6.2 Pfizer Sales, Value, Gross and Gross Margin from 2014-2021
10.6.3 Pfizer Value and Growth Change from 2014-2021
10.6.4 Pfizer Price Change from 2014-2021
10.6.5 Pfizer Product Offered
10.7 Novo Nordisk
10.7.1 Novo Nordisk Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.7.2 Novo Nordisk Sales, Value, Gross and Gross Margin from 2014-2021
10.7.3 Novo Nordisk Value and Growth Change from 2014-2021
10.7.4 Novo Nordisk Price Change from 2014-2021
10.7.5 Novo Nordisk Product Offered
10.8 Eli Lilly
10.8.1 Eli Lilly Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.8.2 Eli Lilly Sales, Value, Gross and Gross Margin from 2014-2021
10.8.3 Eli Lilly Value and Growth Change from 2014-2021
10.8.4 Eli Lilly Price Change from 2014-2021
10.8.5 Eli Lilly Product Offered
10.9 Novartis
10.9.1 Novartis Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.9.2 Novartis Sales, Value, Gross and Gross Margin from 2014-2021
10.9.3 Novartis Value and Growth Change from 2014-2021
10.9.4 Novartis Price Change from 2014-2021
10.9.5 Novartis Product Offered
10.10 Merck
10.10.1 Merck Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.10.2 Merck Sales, Value, Gross and Gross Margin from 2014-2021
10.10.3 Merck Value and Growth Change from 2014-2021
10.10.4 Merck Price Change from 2014-2021
10.10.5 Merck Product Offered
10.11 3sbio
10.11.1 3sbio Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.11.2 3sbio Sales, Value, Gross and Gross Margin from 2014-2021
10.11.3 3sbio Value and Growth Change from 2014-2021
10.11.4 3sbio Price Change from 2014-2021
10.11.5 3sbio Product Offered
10.12 Changchun High Tech
10.12.1 Changchun High Tech Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.12.2 Changchun High Tech Sales, Value, Gross and Gross Margin from 2014-2021
10.12.3 Changchun High Tech Value and Growth Change from 2014-2021
10.12.4 Changchun High Tech Price Change from 2014-2021
10.12.5 Changchun High Tech Product Offered
10.13 CP Guojian
10.13.1 CP Guojian Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.13.2 CP Guojian Sales, Value, Gross and Gross Margin from 2014-2021
10.13.3 CP Guojian Value and Growth Change from 2014-2021
10.13.4 CP Guojian Price Change from 2014-2021
10.13.5 CP Guojian Product Offered
10.14 Biotech
10.14.1 Biotech Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.14.2 Biotech Sales, Value, Gross and Gross Margin from 2014-2021
10.14.3 Biotech Value and Growth Change from 2014-2021
10.14.4 Biotech Price Change from 2014-2021
10.14.5 Biotech Product Offered
10.15 Gelgen
10.15.1 Gelgen Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.15.2 Gelgen Sales, Value, Gross and Gross Margin from 2014-2021
10.15.3 Gelgen Value and Growth Change from 2014-2021
10.15.4 Gelgen Price Change from 2014-2021
10.15.5 Gelgen Product Offered
10.16 Innovent
10.16.1 Innovent Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.16.2 Innovent Sales, Value, Gross and Gross Margin from 2014-2021
10.16.3 Innovent Value and Growth Change from 2014-2021
10.16.4 Innovent Price Change from 2014-2021
10.16.5 Innovent Product Offered
10.17 Dong Bao
10.17.1 Dong Bao Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.17.2 Dong Bao Sales, Value, Gross and Gross Margin from 2014-2021
10.17.3 Dong Bao Value and Growth Change from 2014-2021
10.17.4 Dong Bao Price Change from 2014-2021
10.17.5 Dong Bao Product Offered
10.18 Ganlee
10.18.1 Ganlee Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.18.2 Ganlee Sales, Value, Gross and Gross Margin from 2014-2021
10.18.3 Ganlee Value and Growth Change from 2014-2021
10.18.4 Ganlee Price Change from 2014-2021
10.18.5 Ganlee Product Offered
10.19 United Laboratories
10.19.1 United Laboratories Company Profile (Major Business, Plants Distribution, Sales Region, Contact Information)
10.19.2 United Laboratories Sales, Value, Gross and Gross Margin from 2014-2021
10.19.3 United Laboratories Value and Growth Change from 2014-2021
10.19.4 United Laboratories Price Change from 2014-2021
10.19.5 United Laboratories Product Offered
11. Market Dynamics
11.1 Driving Factors
11.1.1 Rising Demand in Some Regions: North America/Europe/China/India/Japan …
11.1.2 Increasing Use of Biologics Biosimilars by Different End-User/Applications
11.2 Restraints and Challenges in the Market
11.3 Opportunities
11.4 Covid-19 Impact/Evaluation
12. Future Forecast of Global Biologics Biosimilars Market from 2020-2026
12.1 Future Forecast of Global Biologics Biosimilars Market from 2020-2026 Segment by Regions
12.2 Future Forecast of Global Biologics Biosimilars Market from 2020-2026 Segment by Type
12.3 Future Forecast of Global Biologics Biosimilars Market from 2020-2026 Segment by Application
13. Investment Analysis
13.1 Fundamental Analysis (Porter's Five Forces Analysis)
13.2 Technical Preparation Analysis
13.3 Risk Evaluating Analysis
13.4 Estimated Investment Pay-Back Period
14 Research Methodology
14.1 Research Data
14.1.1 Secondary Data
14.1.2 Primary Data
14.2 Revenue Estimation
14.2.1 Bottom-Up Approach
14.2.2 Top-Down Approach (Involves time, Space, and Persons)
14.3 Data Triangulation
14.4 Assumptions
14.5 Hypothesis of this Research, Clear, specific, and testable statement of this research
14.6 Limitations of Our Study
14.7 Scene Based Modeling
15 Disclaimer
Research Methodology:
Biologics Biosimilars Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|